Earnings results expected in 20 days
Summary
BSX trading today lower at $100.48, a decrease of 0.75% from yesterday's close, completing a monthly decrease of -4.17% or $4.37. Over the past 12 months, BSX stock gained 11.62%.
BSX is not paying dividends to its shareholders.
The last earnings report, released on Jan 29, 2025, exceeded the consensus estimates by 0.04%. On average, the company has fell short of earnings expectations by -0.17%, based on the last three reports. The next scheduled earnings report is due on Apr 22, 2025.
The stock of the company had never split.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track BSX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BSX Chart
Boston Scientific Corp Dividends
BSX is not paying dividends to its shareholders.
Boston Scientific Corp Earnings
| 22 Apr 2025 (20 Days) Date | | - Cons. EPS | - EPS |
| 29 Jan 2025 Date | | 0.66 Cons. EPS | 0.7 EPS |
| 24 Oct 2024 Date | | 0.59 Cons. EPS | - EPS |
| 23 Oct 2024 Date | | 0.59 Cons. EPS | 0.63 EPS |
| 25 Jul 2024 Date | | 0.58 Cons. EPS | - EPS |
BSX is not paying dividends to its shareholders.
| 22 Apr 2025 (20 Days) Date | | - Cons. EPS | - EPS |
| 29 Jan 2025 Date | | 0.66 Cons. EPS | 0.7 EPS |
| 24 Oct 2024 Date | | 0.59 Cons. EPS | - EPS |
| 23 Oct 2024 Date | | 0.59 Cons. EPS | 0.63 EPS |
| 25 Jul 2024 Date | | 0.58 Cons. EPS | - EPS |
Boston Scientific Corp (BSX) FAQ
What is the stock price today?
The current price is $100.48.
On which exchange is it traded?
Boston Scientific Corp is listed on NYSE.
What is its stock symbol?
The ticker symbol is BSX.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 133.28B.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on Apr 22, 2025.
Has Boston Scientific Corp ever had a stock split?
No, there has never been a stock split.
Boston Scientific Corp Profile
| Medical Devices Industry | Healthcare Sector | Mr. Michael F. Mahoney CEO | NYSE Exchange | 101137107 Cusip |
| Germany Country | - Employees | - Last Dividend | 6 Nov 2003 Last Split | 18 May 1992 IPO Date |
Overview
Boston Scientific Corporation is a global developer, manufacturer, and marketer of medical devices used in a variety of interventional medical specialties. Having begun its operations in 1979, the company has grown to serve a diverse range of medical needs through its two primary segments: MedSurg and Cardiovascular. With its headquarters in Marlborough, Massachusetts, Boston Scientific is committed to improving patient health by providing cutting-edge solutions that address complex medical conditions and enhance the quality of life for patients worldwide.
Products and Services
- Gastrointestinal and Pulmonary Devices: These include resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes. These devices are aimed at diagnosing and treating conditions within the gastrointestinal and pulmonary systems, offering advanced options for physicians and improved care for patients.
- Urology Devices: Comprising ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincters, lasers, fibers, and hydrogel systems. These products target urological conditions, providing solutions that maintain urinary function and patient quality of life.
- Neurology and Pain Management Devices: This category includes spinal cord stimulator systems, proprietary programming software, radiofrequency generators, indirect decompression systems, practice optimization tools, and deep brain stimulation systems. Designed for treating neurological movement disorders and chronic pain management, these devices help patients return to their normal activities with less discomfort.
- Cardiovascular Technologies: Offering technologies for diagnosing and treating coronary artery disease and aortic valve conditions, including WATCHMAN FLX Left Atrial Appendage Closure Device. Boston Scientific focuses on delivering innovative solutions for heart diseases, aiming to improve patient outcomes and reduce healthcare costs.
- Electrophysiology Devices: Including cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. These products are designed for the diagnosis and treatment of rate and rhythm disorders of the heart, enhancing life quality for patients with heart conditions.
- Diseases of the Peripheral System: Devices targeting peripheral arterial and venous diseases, providing diagnostic and therapeutic options for patients suffering from these circulatory conditions.
- Cancer Diagnosis and Treatment: Offering products that facilitate the diagnosis, treatment, and palliation of various forms of cancer, Boston Scientific aims to contribute to the overall cancer care continuum, from early detection to treatment and beyond.
Contact Information
Address: 300 Boston Scientific Way
Phone: 508 683 4000
Website: https://www.bostonscientific.com
2025 © Marketlog. All Rights Reserved.
